Top FDA drug regulator raises alarms about expediting approvals – The Washington Post
Business News
- Top FDA drug regulator raises alarms about expediting approvals The Washington Post
- In new FDA role, Pazdur will decide the future of Sarepta’s Duchenne drugs statnews.com
- Ellen Sigal and Karen Knudsen “gush” about new CDER Director Richard Pazdur and his late wife, Mary The Cancer Letter
- Longtime FDA Innovator Appointed as Director of Center for Drug Evaluation and Research Florida Hospital News and Healthcare Report
- Makary Got His Man in Pazdur—But Can He Last? RealClearHealth
Source: Business News
